Introduction to the Theme “Cancer Pharmacology”

Literature Cited

1. Mukherjee S. 1.  2010. The Emperor of All Maladies: A Biography of Cancer New York: Scribner [Google Scholar]
2. Hanahan D, Weinberg RA. 2.  2011. Hallmarks of cancer: the next generation. Cell 144:646–74 [Google Scholar]
3. Lazo JS, Sharlow ER. 3.  2016. Drugging undruggable molecular cancer targets. Annu. Rev. Pharmacol. Toxicol. 56:23–40 [Google Scholar]
4. Tong R, Kohane DS. 4.  2016. New strategies in cancer nanomedicine. Annu. Rev. Pharmacol. Toxicol. 5641–57 [Google Scholar]
5. Gross G, Eshhar Z. 5.  2016. Therapeutic potential of T cell chimeric antigen receptors (CARs) in cancer treatment: counteracting off-tumor toxicities for safe CAR T cell therapy. Annu. Rev. Pharmacol. Toxicol. 5659–83 [Google Scholar]
6. Gottesman MM, Lavi O, Hall MD, Gillet JP. 6.  2016. Toward a better understanding of the complexity of cancer drug resistance. Annu. Rev. Pharmacol. Toxicol. 5685–102 [Google Scholar]
7. Bobbin ML, Rossi JJ. 7.  2016. RNA interference (RNAi)-based therapeutics: delivering on the promise?. Annu. Rev. Pharmacol. Toxicol. 56103–22 [Google Scholar]
8. Childs-Disney JL, Disney MD. 8.  2016. Approaches to validate and manipulate RNA targets with small molecules in cells. Annu. Rev. Pharmacol. Toxicol. 56123–40 [Google Scholar]
9. Martinez Molina D, Nordlund P. 9.  2016. The cellular thermal shift assay: a novel biophysical assay for in situ drug target engagement and mechanistic biomarker studies. Annu. Rev. Pharmacol. Toxicol. 56141–61 [Google Scholar]
10. Porteus M. 10.  2016. Genome editing: a new approach to human therapeutics. Annu. Rev. Pharmacol. Toxicol. 56163–90 [Google Scholar]
11. Śledź P, Baumeister W. 11.  2016. Structure-driven developments of 26S proteasome inhibitors. Annu. Rev. Pharmacol. Toxicol. 56191–209 [Google Scholar]
12. Vaught J. 12.  2016. Biobanking comes of age: the transition to biospecimen science. Annu. Rev. Pharmacol. Toxicol. 56211–28 [Google Scholar]
13. Whitaker RM, Corum D, Beeson CC, Schnellmann RG. 13.  2016. Mitochondrial biogenesis as a pharmacological target: a new approach to acute and chronic diseases. Annu. Rev. Pharmacol. Toxicol. 56229–49 [Google Scholar]
14. Yueh MF, Tukey RH. 14.  2016. Triclosan: a widespread environmental toxicant with many biological effects. Annu. Rev. Pharmacol. Toxicol. 56251–72 [Google Scholar]